Posts by Helene Kuhn
Third National Forum on Sepsis
National Sepsis Forum 2016 September 12, 2016 New York, NY. CEO Roz Brandon invited to attend the 3rd National Sepsis Forum 2016 held by the Rory Staunton Foundation, “New Ideas on Sepsis.” New York State has led the country in its holistic approach to sepsis prevention, treatment and awareness. The Third National Forum will showcase the advances made by New…
Read MoreTaking Down The Hospital’s Biggest Killer
By testing white blood cells and monitoring “expression biomarkers,” SeptiCyte – a proprietary technology of Immunexpress – aims to provide faster and more accurate diagnosis of sepsis. By Gregory Zeller.
Read MoreAmerican Thoracic Society (ATS) 2016 International Conference
American Thoracic Society 2016 May 13-18, 2016 San Francisco, CA. Bert Lopansri of Intermountain Health Care presented data on the usage of SeptiCyte™ technology to better inform management and reduce risk for patients in the early stages of ICU admission when other diagnostics available at this time either lack accuracy or are not available.
Read MoreSepsis: 2026
A plenary lecture that took a journey through how we may treat sepsis in 10 years was featured with Steven Opal (Rhode Island Hospital, Providence, RI, USA) stepping up to speak about the expectations, hopes and remaining challenges in the field.
Read MoreSeattle biotech Immunexpress eyes up to $40M for Series C round
Seattle biotech Immunexpress is trying to raise up to $40 million in a Series C round that it plans to close by mid-year. By Rachel Nielsen.
Read MoreAn Interview With Roslyn Brandon from Immunexpress
Dave sits down with Roslyn Brandon from Immunexpress at the JP Morgan Annual Health Conference. In this interview, they discuss the problems of diagnosing sepsis and their innovative solution with SeptiCyte.
Read MoreAn Interview With Roy Davis from Immunexpress
Dave sits down with Roy Davis from Immunexpress while at the JP Morgan Annual Health Conference. In this video, they discuss a new diagnostic test for detecting sepsis in patients.
Read MorePersonalized Medicine World Conference
Personalized Medicine World Conference January 24-27, 2016 Silicon Valley, CA. Invited talk by Leo McHugh on host response transcriptomics for the diagnosis and management on critical infections. Presented results of various SeptiCyte™ validation trials and in-silico analyses for other clinical management related gene expression signatures.
Read MoreImmunexpress, Collaborators Publish Clinical Validation of Host-Response Sepsis Assay
Immunexpress, Inc., committed to improving outcomes for suspected sepsis patients, announced the publication of the discovery and validation of the SeptiCyte® Lab test for sepsis in PLOS Medicine.
Read MoreA Molecular Host Response Assay to Discriminate Between Sepsis and Infection-Negative Systemic Inflammation in Critically Ill Patients: Discovery and Validation in Independent Cohorts
McHugh et al., PLOS Medicine | SeptiCyte Lab is a rapid molecular assay that may be clinically useful in managing ICU patients with systemic inflammation. Further study in population-based cohorts is needed to validate this assay for clinical use.
Read More